Category
Bortezomib
CAS Number
1194235-41-0
Molecular Formula
C28H34BN5O5
Molecular Weight
531.4 g/mol
Synonym

[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]propanoyl]amino]butyl]boronic acid; ((R)-3-Methyl-1-((S)-3-phenyl-2-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)propanamido)butyl)boronic Acid; Bortezomib L-Phenylalanyl Analog (USP); Bortezomib Related Compound O

Keywords
Metabolites.
Heterocycles
boron derivatives
Chiral standards
Intermediates
Pharmaceutical Standards
Fine Chemicals
Amines
Impurities
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Bortezomib Impurity 9 is a designated impurity associated with Bortezomib that may form during chemical synthesis, processing, or storage. It differs structurally from the active drug and is identified, quantified, and controlled under regulatory guidelines to ensure the final pharmaceutical product remains safe, stable, and therapeutically effective.